SCOPUS 정보 검색 플랫폼

Journal of Atherosclerosis and Thrombosis

Volumn 17, Issue 8, 2010, Pages 888-

Ezetimibe, oxidized low density lipoprotein, lp (a), and dyslipidemia

(4) Fonseca, Henrique A R a Izar, Maria C a Bianco, Henrique T a Fonseca, Francisco A a

a FEDERAL UNIVERSITY OF SÃO PAULO (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ARTICLE; ATHEROSCLEROSIS; COMBINATION CHEMOTHERAPY; DRUG EFFECT; DRUG POTENCY; DYSLIPIDEMIA; HUMAN; HYPERLIPIDEMIA; MONOTHERAPY; PARAMETER; TREATMENT RESPONSE;

EID: 77957109232 PISSN: 13403478 EISSN: 18803873 Source Type: Journal
DOI: 10.5551/jat.5918 Document Type: Article

Times cited : (2)

References (5)

1
- 76249132266
- Effects of ezetimibe on remnant-like particle cholesterol, lipoprotein (a), and oxidized low-density lipoprotein in patients with dyslipidemia
- Nozue T, Michishita I, Mizuguchi I: Effects of ezetimibe on remnant-like particle cholesterol, lipoprotein (a), and oxidized low-density lipoprotein in patients with dyslipidemia. J Atheroscler Thromb, 2010; 17: 37-44
- (2010) J Atheroscler Thromb , vol.17 , pp. 37-44
- Nozue, T.¹ Michishita, I.² Mizuguchi, I.³

2
- 45449120489
- Relationship between biomarkers of oxidized low-density lipoprotein, statin therapy, quantitative coronary angiography, and atheroma: Volume observations from the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) study
- Choi SH, Chae A, Miller E, Messig M, Ntanios F, DeMaria AN, Nissen SE, Witztum JL, Tsimikas S: Relationship between biomarkers of oxidized low-density lipoprotein, statin therapy, quantitative coronary angiography, and atheroma: volume observations from the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) study. J Am Coll Cardiol, 2008; 52: 24-32
- (2008) J Am Coll Cardiol , vol.52 , pp. 24-32
- Choi, S.H.¹ Chae, A.² Miller, E.³ Messig, M.⁴ Ntanios, F.⁵ Demaria, A.N.⁶ Nissen, S.E.⁷ Witztum, J.L.⁸ Tsimikas, S.⁹

3
- 63649095045
- JUPITER Trial Study Group: Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: A prospective study of the JUPITER trial
- Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, Macfadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Trial Study Group: Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet, 2009; 373: 1175-1182
- (2009) Lancet , vol.373 , pp. 1175-1182
- Ridker, P.M.¹ Danielson, E.² Fonseca, F.A.³ Genest, J.⁴ Gotto Jr., A.M.⁵ Kastelein, J.J.⁶ Koenig, W.⁷ Libby, P.⁸ Lorenzatti, A.J.⁹ Macfadyen, J.G.¹⁰ Nordestgaard, B.G.¹¹ Shepherd, J.¹² Willerson, J.T.¹³ Glynn, R.J.¹⁴

4
- 33745685706
- Achieving 2003 European lipid goals with rosuvastatin and comparator statins in 6743 patients in real-life clinical practice: DISCOVERY meta-analysis
- Middleton A, Binbrek AS, Fonseca FA, Wilpshaar W, Watkins C, Strandberg TE: Achieving 2003 European lipid goals with rosuvastatin and comparator statins in 6743 patients in real-life clinical practice: DISCOVERY meta-analysis. Curr Med Res Opin, 2006; (6): 1181-1191
- (2006) Curr Med Res Opin , Issue.6
- Middleton, A.¹ Binbrek, A.S.² Fonseca, F.A.³ Wilpshaar, W.⁴ Watkins, C.⁵ Strandberg, T.E.⁶

5
- 67649647665
- Influence of exercise at lower and higher intensity on blood pressure and cardiovascular risk factors at older age
- Cornelissen VA, Arnout J, Holvoet P, Fagard RH: Influence of exercise at lower and higher intensity on blood pressure and cardiovascular risk factors at older age. J Hypertens, 2009; 27: 753-762
- (2009) J Hypertens , vol.27 , pp. 753-762
- Cornelissen, V.A.¹ Arnout, J.² Holvoet, P.³ Fagard, R.H.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.